These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 21714657)

  • 1. Tiotropium versus salmeterol in COPD.
    Restrick L; Stern M; Baxter N
    N Engl J Med; 2011 Jun; 364(26):2552; author reply 2553-4. PubMed ID: 21714657
    [No Abstract]   [Full Text] [Related]  

  • 2. Tiotropium versus salmeterol in COPD.
    Schembri S
    N Engl J Med; 2011 Jun; 364(26):2553; author reply 2553-4. PubMed ID: 21714655
    [No Abstract]   [Full Text] [Related]  

  • 3. Tiotropium versus salmeterol in COPD.
    Oba Y
    N Engl J Med; 2011 Jun; 364(26):2553; author reply 2553-4. PubMed ID: 21714654
    [No Abstract]   [Full Text] [Related]  

  • 4. Tiotropium versus salmeterol in COPD.
    Lloret-Linares C; Bergmann JF
    N Engl J Med; 2011 Jun; 364(26):2552-3; author reply 2553-4. PubMed ID: 21714656
    [No Abstract]   [Full Text] [Related]  

  • 5. Is salmeterol/fluticasone propionate equivalent to tiotropium bromide in the treatment of COPD?
    Gillissen A
    Am J Respir Crit Care Med; 2008 Jul; 178(1):105; author reply 106-7. PubMed ID: 18565963
    [No Abstract]   [Full Text] [Related]  

  • 6. Do we need three players in COPD treatment?
    Maestrelli P; Mason P; Costa F; Paggiaro P
    Respiration; 2013; 86(4):275-6. PubMed ID: 23988429
    [No Abstract]   [Full Text] [Related]  

  • 7. Tiotropium for chronic obstructive pulmonary disease.
    Drug Ther Bull; 2003 Feb; 41(2):15-6. PubMed ID: 12630336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenetics of COPD: a role for the β2-adrenergic receptor gene?
    Jensen CS; Dahl M
    Lancet Respir Med; 2014 Jan; 2(1):3-4. PubMed ID: 24461881
    [No Abstract]   [Full Text] [Related]  

  • 9. Summaries for patients. Combination inhaler therapy for chronic obstructive pulmonary disease.
    Ann Intern Med; 2007 Apr; 146(8):I12. PubMed ID: 17310044
    [No Abstract]   [Full Text] [Related]  

  • 10. Outpatient management of severe COPD.
    Singh S; Loke YK; Furberg CD
    N Engl J Med; 2010 Jul; 363(5):493-4; author reply 494-5. PubMed ID: 20666630
    [No Abstract]   [Full Text] [Related]  

  • 11. Tiotropium step-up therapy in asthma.
    Miller DR; Chetty M; Currie GP
    N Engl J Med; 2011 Feb; 364(6):578; author reply 578-9. PubMed ID: 21306256
    [No Abstract]   [Full Text] [Related]  

  • 12. Tiotropium bromide: a novel once-daily anticholinergic bronchodilator for the treatment of COPD.
    Hansel TT; Barnes PJ
    Drugs Today (Barc); 2002 Sep; 38(9):585-600. PubMed ID: 12582447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The functional impact of adding salmeterol and tiotropium in patients with stable COPD.
    Cazzola M; Centanni S; Santus P; Verga M; Mondoni M; di Marco F; Matera MG
    Respir Med; 2004 Dec; 98(12):1214-21. PubMed ID: 15588043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment step down should be avoided at entry in COPD therapeutic trials.
    Marchand E
    Am J Respir Crit Care Med; 2008 Jul; 178(1):105-6; author reply 106-7. PubMed ID: 18565962
    [No Abstract]   [Full Text] [Related]  

  • 15. An acute bronchodilator test with tiotropium or salmeterol does not allow a subdivision of patients according to responses.
    Matera MG; Sanduzzi A; Ponticiello A; Vatrella A; Salzillo A; Cazzola M
    Respiration; 2005; 72(5):466-70. PubMed ID: 16210884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New therapy for managing moderate to severe chronic obstructive pulmonary disease.
    Chou A; D'Urzo AD
    Can Fam Physician; 2014 Apr; 60(4):352-4. PubMed ID: 24733327
    [No Abstract]   [Full Text] [Related]  

  • 17. Stepping down therapy in COPD.
    Reilly JJ
    N Engl J Med; 2014 Oct; 371(14):1340-1. PubMed ID: 25196116
    [No Abstract]   [Full Text] [Related]  

  • 18. [Dyspnea and quality of life in chronic obstructive pulmonary disease].
    Sanjuás C
    Arch Bronconeumol; 2002 Oct; 38(10):485-8. PubMed ID: 12372199
    [No Abstract]   [Full Text] [Related]  

  • 19. Tolerance to bronchodilating effects of salmeterol in COPD.
    Donohue JF; Menjoge S; Kesten S
    Respir Med; 2003 Sep; 97(9):1014-20. PubMed ID: 14509555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bronchodilation improves endurance but not muscular efficiency in chronic obstructive pulmonary disease.
    van der Vaart H; Postma DS; Grevink R; Roemer W; ten Hacken N
    Int J Chron Obstruct Pulmon Dis; 2011; 6():229-35. PubMed ID: 21660300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.